Tags Biotechnology

Tag: Biotechnology News

Microcide Announces Launch of Speed-breaker for Fast Moving COVID-19 Infections for Health Care Facilities

STERLING HEIGHTS, Mich., Jan. 4, 2021 (SEND2PRESS NEWSWIRE) -- Microcide® Inc. a leading Michigan based biotechnology company, today announced the test results of its COVID-19 faster virus killing range of products, PRO-SAN® Cleaner sanitizer, SILKY-SOFT® hand sanitizer, and DENTORAL® mouthwash.

Synthetic Biology for Tennessee Schools: BioBuilder Partners with Niswonger Foundation on $8.8M Federal Grant for STEM Education

CAMBRIDGE, Mass., Dec. 29, 2020 (SEND2PRESS NEWSWIRE) -- The BioBuilder Educational Foundation announced that they are to partner with the Niswonger Foundation on their award of an "Education Innovation and Research" (EIR) Grant from the U.S. Department of Education that will focus on educational opportunities in Science, Technology, Engineering and Mathematics (STEM).

Pure Protein, LLC Announces New Website Now Offering Its HLA Reagents and Technical Services to Researchers

OKLAHOMA CITY, Okla. and AUSTIN, Texas, Nov. 30, 2020 (SEND2PRESS NEWSWIRE) -- Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), is proud to announce the launch of its new website.

Zeteo Biomedical to Collaborate with Iowa State University Nanovaccine Institute to Study a COVID 19 Vaccine Under Fast Track CARES Act...

AUSTIN, Texas, Nov. 17, 2020 (SEND2PRESS NEWSWIRE) -- Zeteo Biomedical LLC, Inc., a privately held medical device company, has partnered with the Nanovaccine Institute at Iowa State University to study a nasal SARS-CoV-2 vaccine. Zeteo will provide nasal delivery device technology and unit dose packaging utilizing its ZEOx2 Delivery Platform.

Avila Herbals Announces Manufacturing and Research and Development Agreements with Phoenix Biotechnology

CHRISTIANSBURG, Va., Oct. 28, 2020 (SEND2PRESS NEWSWIRE) -- Avila Herbals, a company specializing in novel botanical extraction techniques for both dietary supplements and pharmaceuticals, announced today that it has signed an exclusive global manufacturing agreement and a research and development agreement with Phoenix Biotechnology.
Progenabiome Shares New Data on Fecal Transplant, Sars-Cov-2

Biotech Firm, Progenabiome Shares New Data on Fecal Transplant, Sars-Cov-2 at ACG 2020

VENTURA, Calif. /California Newswire/ -- The American College of Gastroenterology (ACG) named Progenabiome "Outstanding Poster Presenter" for its poster: "Successful Bacterial Engraftment Identified by Next Generation Sequencing Following Fecal Microbiota Transplantation for Clostridioides difficile Infection," which will be presented virtually at the ACG Annual Scientific Meeting this week.

Pure Protein, LLC to Exhibit and Preview New Website at the American Society for Histocompatibility and Immunogenetics (ASHI) 46th Annual Meeting

OKLAHOMA CITY, Okla. and AUSTIN, Texas, Oct. 15, 2020 (SEND2PRESS NEWSWIRE) -- Pure Protein, LLC (Pure Protein) an HLA company that has developed comprehensive analytical capabilities in the field of human leukocyte antigen (HLA) immunology and an approach to produce soluble forms of the HLA molecule (sHLA), announced today that it will be an exhibitor at the ASHI VIRTUAL ANNUAL MEETING, October 19 - 21, 2020.

Zeblok Computational Announces Partnership with Laufer Center and CEWIT – COVID-19 Drug Discovery

STONY BROOK, N.Y., July 20, 2020 (SEND2PRESSN NEWSWIRE) -- Zeblok Computational is contributing to the efforts of two groups of researchers at The Laufer Center for Physical and Quantitative Biology, for COVID-19 drug discovery by providing Zeblok's secure, scalable Supercomputing-as-a-Service platform, employing 128 GPUs from the CEWIT SMART GPU Cluster.
ROKiT Pharma

ROKiT Pharma Pre-clinical Studies Show Tremendous Promise for Naturally Derived Cancer Drug, ROK-001

LOS ANGELES, Calif. /California Newswire/ -- ROKiT Pharma, Inc., a public-benefit corporation dedicated to putting patients first, announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.
Bay Area Lyme Foundation

Bay Area Lyme Foundation announces Lyme Disease Biobank Expands Into San Diego

SAN DIEGO, Calif. /California Newswire/ -- Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., announces the opening of the San Diego collection site of the Bay Area Lyme Foundation's Lyme Disease Biobank, which is the first program to provide researchers with blood and urine samples from people with early Lyme disease from multiple endemic regions across the country.

iCell Gene Therapeutics Announces CAR-T Oral and Poster Presentations at 61st American Society of Hematology Annual Meeting

STONY BROOK, N.Y., Nov. 14, 2019 (SEND@PRESS NEWSWIRE) -- iCell Gene Therapeutics, a clinical stage biopharmaceutical company focused on immunotherapies for hematologic malignancies, solid tumors, organ rejections and autoimmune disorders, announced today that it will give oral and poster presentations related to its BCMA-CD19 cCAR and CD4-specific CAR programs at the 61st American Society of Hematology (ASH) Annual Meeting to be held December 7-10, 2019 in Orlando, Florida.

Hans van der Sluijs Joins BioTork as Chief Development Officer

GAINESVILLE, Fla., Oct. 30, 2019 (SEND2PRESS NEWSWIRE) -- BioTork, the leading evolution biotechnology company, today announced that biotech executive Hans van der Sluijs has joined the company as Chief Development Officer. Hans brings over 20 years of international business leadership experience, with a focus on business development, management, and building strategic alliances/partnerships.
neurotech leaders forum 2019

Neurotech Leaders Forum 2019 in San Francisco: Fifteen Neurotechnology Startups to Present at the Event

SAN FRANCISCO, Calif. /California Newswire/ -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5. The 19th annual event-the most established in the industry-will also feature presentations and panel discussions on important issues confronting the neurotechnology industry.

Brandon Stem Cell Clinic Offers Life-changing Treatment Options

TAMPA, Fla., Aug. 12, 2019 (SEND2PRESS NEWSWIRE) -- Brandon Stem Cell Clinic (BSCC) recognizes that osteoarthritis is one of the most common joint conditions, affecting nearly 630 million people worldwide. It is commonly associated with aging but is also frequently seen in cases of overuse of joints. The growing number of cases alone prove a need for innovative and effective treatments as populations continue to age. (VIDEO)
Market for Bioelectronic Medicine

Neurotech Reports: New Market Research Report on Bioelectronic Medicine Forecasts $16.6B Market

SAN FRANCISCO, Calif. /California Newswire/ -- A newly published market research report from Neurotech Reports, the leading market intelligence firm in the neurotechnology industry, forecasts that the worldwide market for bioelectronic medicine and related technologies will reach $16.6 billion by 2025.

The C Diff Foundation Has Declared an Urgent Need to Raise Clostridium difficile Infection Clinical Trial Awareness Worldwide

TAMPA, Fla., Feb. 21, 2019 (SEND2PRESS NEWSWIRE) -- The C Diff Foundation announced today that their organization has implemented a global campaign to raise awareness of Clostridioides difficile clinical trials, clinical studies, clinical research and observational studies evaluating interventions for C. difficile prevention, treatments, and environmental safety.

Sue Siegel to Keynote 2019 Bioelectronic Medicine Forum in NY

NEW YORK, N.Y., Feb. 20, 2019 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announces that Sue Siegel, Chief Innovation Officer at GE and CEO of GE Ventures, will keynote the 2019 Bioelectronic Medicine Forum, which takes place in New York City on April 4, 2019.

Neurotech Reports Announces 2018 Investment and Management Conference for Bioelectronic Medicine in NYC

NEW YORK, N.Y., Jan. 30, 2018 (SEND2PRESS NEWSWIRE) -- Neurotech Reports, the publisher of Neurotech Business Report newsletter, today announced the launch of the Bioelectronic Medicine Forum, the first investment and management conference for the bioelectronic medicine industry. The inaugural event will take place on March 22, 2018 at the Millennium Broadway Times Square in New York, N.Y.

Iron Dust from Vehicle Brakes and Worldwide Magnesium Deficiencies are Contributing to Hypertension says Dr. Rowe

KESWICK, Va., Nov. 14, 2017 (SEND2PRESS NEWSWIRE) -- With 25 years of research involving primarily the cardiovascular complications of spaceflight and more recently of the moon walkers, particularly Neil Armstrong on his historic mission and James Irwin (Apollo 15), extraordinary findings were discovered. Both had vascular complications, triggered by inhalation of deadly iron-laden dust. Author Dr. William J. Rowe has applied this information as to how this can be utilized for underlying mechanisms of hypertension on earth, triggered by iron-laden brake dust.

U.S. Medical Experts Unite Regarding Health Benefits of Testosterone Therapy in Women

IRVING, Texas, April 19, 2017 (SEND2PRESS NEWSWIRE) - BioTE(R) Medical announces a forum of medical experts gathering before the Age Management Medicine Group (AMMG) to form consensus on testosterone therapy in women. The AMMG conference runs April 27-30, 2017 in Orlando, Florida.
2016 Neurotech Leaders Forum

2016 Neurotech Leaders Forum welcomes Key Startups and Industry Figures in San Francisco

SAN FRANCISCO, Calif. /California Newswire/ -- Several promising neurotechnology firms and key industry figures will present at the 2016 Neurotech Leaders Forum. The 16th annual event will take place October 24-25 in San Francisco, presented by Neurotech Reports. Keynote speaker at this year's event on October 24 will be Doug Weber, who serves as program manager for DARPA's Biological Technologies Office.

FEATURED STORIES